- Psychedelic compound shown to slow aging in new research
- Roche trial seeks to prevent Alzheimer’s in at-risk patients
- New data supports Cyclarity’s approach to atherosclerosis reversal
- Cancer-focused biotech makes Alzheimer’s breakthrough
- Think it’s just aging? Why dementia is missed for 3. 5 years on average
- Is the air you breathe silently fueling dementia? A 29-million-person study says yes
- What happens when longevity meets ideology?
- Longevity biotech to spin up new klotho-targeting therapeutics
- Making hormone monitoring as easy as heart rate
- Australian longevity clinic lands $10m for international expansion
- Repurposed drugs show promise in Alzheimer’s combination therapy
- Protein degrader trial targets chronic inflammation
- Blue Longevity raises €2 million to scale preventive health clinics
- New research collaboration targets cellular rejuvenation
- Magic mushrooms rewind aging in mice—could they do the same for humans?
- Physicist, 90, joins experimental trial to challenge age limits
- Climbing the ALS mountain
- FDA doubles down on neurodegeneration
- A tiny chemistry hack just made mRNA vaccines safer, stronger, and smarter
- Doctors used music instead of medication—what they saw in dementia patients was remarkable
- Lonza 4D-Nucleofector X and Y Units
- Lonza 4D-Nucleofector 96-well Unit
- Is aging a disease?
- Mitochondrial modulation drives tissue repair in chronic disease
- Radical life extension fund launches in Singapore
- Three-person DNA IVF stops inherited disease—eight healthy babies born in UK first
- The silent threat: How hearing loss and loneliness are fueling memory decline
- Chronic conditions in midlife linked to dementia risk
- Whoop pushes back on FDA blood pressure warning
- We need new regulation to keep up with longevity innovation